Pharmaceutical firms’ liquidity conditions remain sound

Published: 2011-11-07 06:57:00

Updated: 2011-11-07 06:57:00

Listed drug firms’ liquidity conditions remained firm in June as companies are set to issue more corporate bonds and increase borrowings as part of efforts to secure capital on worries the ongoing uncertainty will continue due to the government’s plan to cut generic drug prices by up to 14 percen...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK